Intensive immunoablation and autologous blood stem cell transplantation in patients with refractory rheumatoid arthritis: the University of Nebraska experience.
D000046:Academic Medical Centers; D000328:Adult; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007937:Leukapheresis; D008297:Male; D008875:Middle Aged; D009329:Nebraska; D010865:Pilot Projects; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous; D016896:Treatment Outcome